Weight Management.

Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone your gut releases after eating. It tells your brain you are full, slows how quickly your stomach empties, and helps regulate blood sugar.

This plan is for patients already taking semaglutide who want to continue treatment at their current, established dose. Semaglutide is a GLP-1 receptor agonist, compounded here with the amino acid glycine.

Tirzepatide is the first medication that acts on two gut hormones at once: GLP-1 and GIP. Together, these signals reduce appetite, slow digestion and improve how your body handles sugar and fat.

Tirzepatide acts on two gut hormones, GLP-1 and GIP, to reduce appetite and improve how your body handles sugar and fat. This formula adds vitamin B12, which your body needs for energy metabolism and healthy nerve and red blood cell function.

This plan is for patients already taking tirzepatide who want to continue at their current, established dose. Tirzepatide works on two gut hormones, GLP-1 and GIP. This formula adds vitamin B12 to support energy metabolism.

Metformin is one of the most widely prescribed medications in the world, with more than 60 years of use. It is a first-line treatment for type 2 diabetes and is often prescribed off-label for insulin resistance and weight management. It is also being studied for its potential role in healthy aging.